FESTARI, CRISTINA
 Distribuzione geografica
Continente #
NA - Nord America 132
EU - Europa 102
AS - Asia 46
SA - Sud America 1
Totale 281
Nazione #
US - Stati Uniti d'America 132
DE - Germania 32
CZ - Repubblica Ceca 25
CN - Cina 16
SG - Singapore 16
HK - Hong Kong 8
UA - Ucraina 8
PL - Polonia 7
IT - Italia 6
RU - Federazione Russa 5
GB - Regno Unito 4
VN - Vietnam 4
FI - Finlandia 3
BE - Belgio 2
IE - Irlanda 2
LV - Lettonia 2
PT - Portogallo 2
SE - Svezia 2
EC - Ecuador 1
FR - Francia 1
JP - Giappone 1
KG - Kirghizistan 1
NO - Norvegia 1
Totale 281
Città #
Fairfield 20
Olomouc 15
Boardman 14
Ashburn 13
Brno 10
Houston 10
Woodbridge 9
Hong Kong 8
Singapore 7
Cambridge 6
Chandler 6
Jacksonville 6
Seattle 6
Shanghai 6
Warsaw 6
Brescia 5
Dearborn 5
Wilmington 5
Dong Ket 4
Munich 4
New York 4
Princeton 4
Beijing 3
Helsinki 3
Brussels 2
Des Moines 2
Dublin 2
Leipzig 2
Riga 2
Ann Arbor 1
Bishkek 1
Guayaquil 1
Hangzhou 1
Hebei 1
Jinan 1
Kunming 1
Lisbon 1
Los Angeles 1
Miami Beach 1
Nanjing 1
Norwalk 1
Nürnberg 1
Oslo 1
San Diego 1
San Francisco 1
Stockholm 1
Tianjin 1
Tokyo 1
Treviolo 1
Walnut 1
Washington 1
Totale 211
Nome #
Do Beliefs about the Pathogenetic Role of Amyloid Affect the Interpretation of Amyloid PET in the Clinic. 130
Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly 71
Comparison of visual criteria for amyloid-pet reading: Could criteria merging reduce inter-rater variability? 14
Automatic multispectral MRI segmentation of human hippocampal subfields: an evaluation of multicentric test-retest reproducibility 12
Automated assessment of FDG-PET for differential diagnosis in patients with neurodegenerative disorders 8
Diagnostic utility of FDG-PET in the differential diagnosis between different forms of primary progressive aphasia 8
Assessing FDG-PET diagnostic accuracy studies to develop recommendations for clinical use in dementia 7
Diagnostic utility of 18F-Fluorodeoxyglucose positron emission tomography (FDG-PET) in asymptomatic subjects at increased risk for Alzheimer’s disease 6
Clinical utility of FDG-PET in amyotrophic lateral sclerosis and Huntington’s disease 6
Clinical utility of FDG-PET for the clinical diagnosis in MCI 6
Clinical utility of FDG-PET for the differential diagnosis among the main forms of dementia 6
Clinical utility of FDG PET in Parkinson’s disease and atypical parkinsonism associated with dementia 5
European Association of Nuclear Medicine and European Academy of Neurology recommendations for the use of brain 18 F-fluorodeoxyglucose positron emission tomography in neurodegenerative cognitive impairment and dementia: Delphi consensus 5
Medial temporal lobe atrophy and posterior atrophy scales normative values 5
Harmonizing neuropsychological assessment for mild neurocognitive disorders in Europe 4
Quantitative appraisal of the Amyloid Imaging Taskforce appropriate use criteria for amyloid-PET 4
Totale 297
Categoria #
all - tutte 1.943
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.943


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202044 6 2 2 4 3 8 6 4 3 4 0 2
2020/202140 0 2 0 2 0 1 1 6 9 9 6 4
2021/202218 3 1 0 2 0 2 0 2 0 1 2 5
2022/202322 3 2 0 2 3 3 0 3 5 1 0 0
2023/2024116 4 2 8 0 4 9 1 2 10 15 10 51
2024/202513 13 0 0 0 0 0 0 0 0 0 0 0
Totale 297